2001-01-11T00:00:00
The Multiple Sclerosis Society has condemned as 'breathtaking bungling' the announcement by the National Institute for Clinical Excellence that no decision on the drugs beta interferon and glatiramer acetate will be made before July 2001. NICE said new evidence had come to light which needed to be taken into account.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. 5th Floor, Aldgate Tower, 2 Leman Street, London E1 8FA. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud